Skip to main content
Thomas Leblanc, MD, Oncology, Durham, NC, Duke University Hospital

ThomasWilliamLeblancMDMA, MHS, FAAHPM

Oncology Durham, NC

Hematologic Oncology, Hospice & Palliative

Associate Professor of Medicine, Division of Hematologic Malignancies and Cellular Therapy

Dr. Leblanc is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Leblanc's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hospice and Palliative Medicine, 2011 - 2012
  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2010
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2006 - 2009
  • Duke University School of Medicine
    Duke University School of MedicineClass of 2006

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2006 - 2024
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Alpha Omega Alpha
  • Research Scholar Award American Academy of Hospice and Palliative Medicine
  • Junior Career Development Award Grant National Palliative Care Research Center (NPCRC)

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effectiveness of Integrated Palliative and Oncology Care for Patients with Acute Myeloid Leukemia  
    Areej El-Jawahri, Thomas W Leblanc, Selina M Luger, Bhavana Bhatnagar, Alison R Walker, Amir T Fathi, Andrew M Brunner, Gabriela S Hobbs, Jennifer S Temel, JAMA Oncology
  • The Experiences of Older Caregivers of Cancer Patients Following Hospital Discharge  
    Richard F Riedel, Ellen Mahoney, Thomas W LeBlanc, Cristina C Hendrix, Supportive care in cancer
  • Transfusion Dependence, Use of Hospice Services, and Quality of End-of-Life Care in Leukemia  
    Thomas Leblanc, MD, Blood

Abstracts/Posters

  • Understanding Clinician and Patient Preferences about Novel Agents in Chronic Lymphocytic Leukemia
    Thomas W. LeBlanc, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Billed Palliative Care Services and End-of-Life Care in Patients with Hematologic Malignancies
    Thomas W. LeBlanc, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Real-World Treatment Patterns and Overall Survival Among Medicare Fee-for-Service Beneficiaries Newly Diagnosed with Peripheral T-Cell Lymphoma
    Thomas W. LeBlanc, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Treatment Decision Making in AML: Factors of Importance to Clinicians, AML Patients and Their Family 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A video decision aid to improve acute myeloid leukemia patients’ illness understanding: Results of a pilot trial. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Prognostic Understanding in Cancer Care: How Well Do Patients Understand Their Illness? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual Meeting
    Astellas to Present Research on FLT3 Mutation-Positive Acute Myeloid Leukemia - from Diagnosis to Relapse - at 2021 American Society of Hematology Annual MeetingDecember 1st, 2021
  • Sorsogon’s Deaf and Blind School Children to Benefit from PHL-US 1st Inclusive Education Center
    Sorsogon’s Deaf and Blind School Children to Benefit from PHL-US 1st Inclusive Education CenterFebruary 26th, 2020
  • & # 39; How Much Time Do I Have? & # 39; New Online Tool for Cancer Patients
    & # 39; How Much Time Do I Have? & # 39; New Online Tool for Cancer PatientsFebruary 3rd, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations